#pharmaceutical market size
Global pharma sales to reach $1.3 trillion
The 2015 CMR Pharmaceutical R D Factbook reveals a surge in global sales – reaching a milestone of $1 trillion in 2014 – and forecasts continued growth with the expectation of sales reaching $1.3 trillion by 2018.
The pharmaceutical market is not in an “Era of Scarcity” as some analysts describe the Pharma R D environment post-2005. Industry data challenges negative perceptions and demonstrates the pharma industry’s continued commitment to creating and employing innovative solutions to tackle its largest hurdles.
Key highlights from the 2015 Factbook include:
Diversification is increasing New Molecular Entities (NME) launches
2014 saw the highest amount in 17 years with 46 NME launches. One third of 2014 launches were for rare indications, mainly within Anti-cancer. More than 65 percent were specialty drugs for the treatment of Anti-cancer, Hepatitis C Virus and HIV.
Anti-cancer development continues to attract the greatest amount of investment across all therapeutic areas. The majority of recent launches have received orphan drugs status from regulatory authorities.
Failing fast and cheaply
An improved ability to “fail fast and cheaply” has enabled Phase III pipeline volumes to grow at a steady rate.
Our Factbook has been built in collaboration with the leading global pharmaceutical companies since 2003. The analysis draws on data from proprietary, primary sources, competitive intelligence, and public sources covering key trends across the landscape, including:
- R D pipeline volume
- Success rates
- Cycle times
- Regional comparisons
- Therapeutic areas
Thomson Reuters feedback